We also hypothesize that patients with Down syndrome might be more susceptible to poor COVID-19 outcomes because the TMPRSS2 gene, a serine protease for SARS-CoV-2 spike protein priming for viral host cell entry, is located on the 21q22.3 gene (27), a critical part of the Down syndrome region. The gene discussed is TMPRSS2; the disease is COVID-19.